Naproxen for Post-Operative Pain
- PMID: 33600307
- DOI: 10.18433/jpps31629
Naproxen for Post-Operative Pain
Abstract
Introduction: Post-operative pain is a common type of acute pain that can require therapeutic intervention. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to manage post-operative pain and help reduce or eliminate the use of opioids. Current pain management guidelines recommend administration of NSAIDs as first line therapy to all post-operative surgical patients, unless contraindicated, as one method to minimize opioid use.
Methods: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by the author. Literature for controlled trials involving naproxen in a peri-procedural setting was included. Comprehensive meta-analyses and individual clinical trial reports were summarized.
Results: Naproxen was shown to have significant efficacy in treating pain following different surgical interventions, eliminating, or reducing the use of rescue opioids in many trials. Importantly, naproxen did not demonstrate an increased rate of bleeding or other adverse events in this elevated-risk population.
Conclusion: As a generally safe and effective medication, clinical consideration should be given to naproxen when developing any comprehensive, patient-specific, pain management plan.
Similar articles
-
The comparative efficacy of naproxen sodium and pirprofen in the treatment of post-operative pain.J Int Med Res. 1987 May-Jun;15(3):179-87. doi: 10.1177/030006058701500309. J Int Med Res. 1987. PMID: 3301458 Clinical Trial.
-
Efficacy and Safety of Naproxen for Acute Pain.J Fam Pract. 2020 Sep;69(7 Suppl):S33-S38. J Fam Pract. 2020. PMID: 33104105
-
The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty.Acta Anaesthesiol Scand. 2005 Nov;49(10):1491-500. doi: 10.1111/j.1399-6576.2005.00782.x. Acta Anaesthesiol Scand. 2005. PMID: 16223396 Clinical Trial.
-
What a pain in the … back: a review of current treatment options with a focus on naproxen sodium.J Pharm Pharm Sci. 2024 Feb 7;27:12384. doi: 10.3389/jpps.2024.12384. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 38384362 Free PMC article. Review.
-
Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs).Otolaryngol Head Neck Surg. 2021 Apr;164(4):712-719. doi: 10.1177/0194599820947013. Epub 2020 Aug 18. Otolaryngol Head Neck Surg. 2021. PMID: 32806991 Review.
Cited by
-
Visible-Light-Induced Photocatalytic Degradation of Naproxen Using 5% Cu/TiO2, Transformation Products, and Mechanistic Studies.Molecules. 2024 Dec 5;29(23):5752. doi: 10.3390/molecules29235752. Molecules. 2024. PMID: 39683909 Free PMC article.
-
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain.Pharmaceutics. 2023 Aug 5;15(8):2088. doi: 10.3390/pharmaceutics15082088. Pharmaceutics. 2023. PMID: 37631302 Free PMC article. Review.
-
Basil seed mucilage as a bioadhesive polymer: Development of naproxen sodium microspheres and suppositories with in-vitro and ex-vivo studies.ADMET DMPK. 2024 Oct 3;12(6):881-901. doi: 10.5599/admet.2372. eCollection 2024. ADMET DMPK. 2024. PMID: 39713257 Free PMC article.
-
Toxicity of pharmaceutical micropollutants on common carp (Cyprinus carpio) using blood biomarkers.Sci Rep. 2025 May 28;15(1):18748. doi: 10.1038/s41598-025-01434-z. Sci Rep. 2025. PMID: 40436894 Free PMC article.
-
Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity.Pharmaceutics. 2024 May 7;16(5):626. doi: 10.3390/pharmaceutics16050626. Pharmaceutics. 2024. PMID: 38794288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials